Tocotrienol
Tocotrienol (Vitamin E complex)
One small Malaysian RCT showed a hair-count increase. Never replicated. Used by Nutrafol to justify its tocotrienol content.
How Tocotrienol works — and how well we know it
Tocotrienols are members of the vitamin E family with stronger antioxidant activity than alpha-tocopherol. Hypothesized to reduce oxidative stress in scalp tissue, which has been correlated with AGA in some studies.
oral
100 mg/day mixed tocotrienol capsules (studied dose).
Available as a dietary supplement. Distinct from the more common alpha-tocopherol form of vitamin E.
Speculative. As a low-risk add-on for users already on proven therapy who want a possible antioxidant adjunct.
Evidence distribution across 1 claims
Why the grade is D. One small Malaysian RCT (n=21 active / n=17 placebo) showed a 34% mean hair-count increase. Never independently replicated. Mechanism is plausible but indirect.
Every claim, traced back to its source
We took every major claim made about Tocotrienol and matched it to the specific experimental model behind it. Click a claim to see the model, the finding, and our assessment of how much weight it deserves.
1 claims · evidence-by-evidence breakdown
1RCTWeight: LowBeoy 2010: 100 mg/day mixed tocotrienol increased hair count vs. placebo over 8 monthsSingle small RCT with an unusually large effect size that has never been independently replicated. Treat as hypothesis-generating only.
Randomized, double-blind, placebo-controlled trial, n=38 (21 active, 17 placebo), 8 months. Adult volunteers with mild AGA. Active arm received 100 mg/day mixed tocotrienol; placebo received soy oil capsules.
Mean hair count in the active arm increased by 34.5% vs. baseline; placebo arm decreased by 0.1%. Difference statistically significant.
The only RCT of tocotrienol for AGA. Small sample, single site, never replicated independently. The effect size is implausibly large for a non-androgen-targeted intervention — larger than minoxidil in similar populations. Either tocotrienol is more effective than minoxidil for AGA (unlikely on mechanism) or there's a methodological issue with the trial. Until replication, this is interesting but should not drive treatment decisions.
- Beoy LA, Woei WJ, Hay YK (2010). Trop Life Sci Res PMID 24575202
What's still missing from the science
- Any independent replication of the Beoy 2010 trial.
- A larger (>100) multi-center RCT.
- Direct comparison to minoxidil or finasteride.
- Mechanism-of-action studies in human follicles.
Our verdict on Tocotrienol
Not in our formulary yet
We don't carry this ingredient. We only formulate around actives where the evidence — and the safety profile — is strong enough to recommend with confidence. As the data matures, we may revisit.
Related treatments
How does Tocotrienol stack up against its closest peers?
A genuine cause of reversible hair shedding in iron-deficient patients — but useless and potentially harmful if your iron stores are normal.
Read the breakdown →A botanical 5-alpha reductase inhibitor whose only high-quality trials (in BPH) showed no benefit over placebo; the positive AGA data are small and low-quality.
Read the breakdown →Correlated with AGA in observational studies. No RCT yet shows that supplementation reverses or slows hair loss.
Read the breakdown →